CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... DNA templates for expression of gRNAs for different genome-editing applications in a cell-free one-pot reaction. Characterization of the ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about genetic safety and efficacy.

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...

9 In addition to its application in infectious diseases, there are several CRISPR-based developments for the diagnosis of other diseases, including cancer, where it is being used to detect cancer ...

He said CRISPR technology applications hold great promise to be ... (Courtesy of James Stiltner) CRISPR/Cas9 kits provide miniature experimental set-ups that allow individual students to visualize ...

European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948 ... from ERS Genomics for both research use and commercial applications outside of the direct use of CRISPR as a human therapeutic.

Study advances gene-editing capabilities for cancer and medical research through genetic manipulations using Cas12a enzyme ...

CTX001 is an ‘ex vivo’ application of gene-editing, in which the technology is used to modify a patient’s own cells outside the body. It uses CRISPR/Cas9 to make a patient’s haematopoietic ...